BX Swiss TOP 30 CHF
1.373,23
PKT
+13,12
PKT
+0,96
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.10.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 12.10.12 | UBS outperform | Credit Suisse Group | |
| 12.10.12 | Novartis reduce | Vontobel Research | |
| 12.10.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 12.10.12 | Roche neutral | Nomura | |
| 12.10.12 | Roche outperform | Credit Suisse Group | |
| 12.10.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 12.10.12 | Novartis buy | UBS AG | |
| 11.10.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 11.10.12 | Roche buy | Deutsche Bank AG | |
| 11.10.12 | Novartis buy | Deutsche Bank AG | |
| 11.10.12 | Novartis buy | UBS AG | |
| 11.10.12 | Swisscom neutral | Nomura | |
| 11.10.12 | Nestlé overweight | Morgan Stanley | |
| 11.10.12 | Kühne + Nagel International hold | Vontobel Research | |
| 10.10.12 | UBS overweight | J.P. Morgan Cazenove | |
| 10.10.12 | Nestlé neutral | UBS AG | |
| 10.10.12 | Richemont neutral | Credit Suisse Group | |
| 10.10.12 | Kühne + Nagel International underperform | Cheuvreux SA | |
| 10.10.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 10.10.12 | Julius Bär buy | Nomura | |
| 10.10.12 | Givaudan equal-weight | Morgan Stanley | |
| 10.10.12 | Givaudan hold | Vontobel Research | |
| 09.10.12 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 09.10.12 | Givaudan reduce | Nomura | |
| 09.10.12 | ABB (Asea Brown Boveri) underperform | Cheuvreux SA | |
| 09.10.12 | Kühne + Nagel International buy | Nomura | |
| 09.10.12 | Julius Bär buy | Sarasin Research | |
| 09.10.12 | Givaudan neutral | Sarasin Research | |
| 09.10.12 | Givaudan hold | Vontobel Research | |
| 09.10.12 | Holcim outperform | Sanford C. Bernstein and Co., Inc. | |
| 08.10.12 | Novartis halten | Independent Research GmbH | |
| 08.10.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 08.10.12 | Novartis reduce | Vontobel Research | |
| 05.10.12 | Givaudan neutral | UBS AG | |
| 05.10.12 | Lonza hold | Vontobel Research | |
| 05.10.12 | Swiss Re neutral | Sarasin Research | |
| 05.10.12 | Sonova neutral | Sarasin Research | |
| 05.10.12 | Roche kaufen | Fuchsbriefe | |
| 05.10.12 | Straumann hold | Vontobel Research |